MDHOET

MDHOET is a psychoactive compound with chemical structure similar to other substances in the phenethylamine class, which includes many stimulants, entactogens, and hallucinogens. As a lesser-known member of this class, MDHOET's pharmacology, effects, and history are not as well-documented as those of its more famous counterparts, such as MDMA (ecstasy) or mescaline. Due to the lack of extensive research, information on MDHOET remains sparse, and it is primarily of interest within the context of psychedelic research and designer drugs.

Chemistry

MDHOET belongs to the substituted phenethylamine family, a broad category of compounds with a basic phenethylamine structure that is modified by various chemical groups. These modifications can significantly alter the compounds' pharmacological effects. The "MD" prefix in its name suggests a methylenedioxy group, similar to that found in MDMA, which can affect its potency, duration, and subjective effects.

Pharmacology

The pharmacological action of MDHOET, like many research chemicals, is not well understood. However, it is presumed to act as a serotonin, dopamine, and norepinephrine releaser or reuptake inhibitor, which is a common mechanism among entactogens and stimulants. This action can lead to euphoria, increased sociability, and altered sensory perception, but can also pose risks of neurotoxicity, cardiovascular issues, and psychological dependency.

Effects

Users of MDHOET may experience effects similar to other phenethylamines, including enhanced mood, empathy, and altered visual and auditory perception. However, without significant scientific study, the specific effects, potency, duration, and safety profile of MDHOET remain speculative.

Legal Status

The legal status of MDHOET varies by country, but it may be controlled under analog acts or specific legislation targeting psychoactive substances. In jurisdictions where analog laws apply, MDHOET could be considered illegal if it is structurally similar to a controlled substance.

Research and History

MDHOET has not been widely studied, and its history of use is largely undocumented. It likely emerged on the designer drug market as an alternative to more regulated phenethylamines. The lack of research and information on MDHOET makes it a compound of interest primarily to chemists and researchers studying the effects of psychoactive substances.

‎